Australia (TGA)
Therapeutic Goods Administration listing and ARTG pathways.
Service · Regulatory Compliance
Regulatory compliance is the difference between a product that sells and a product that sits in a warehouse. We map the pathway before anything goes to print.
Scope
Therapeutic Goods Administration listing and ARTG pathways.
Cosmetic Products Notification Portal submissions.
Submit Cosmetic Product Notification for the post-Brexit UK market.
Saudi Arabia, UAE, Kuwait, Bahrain, Qatar and Oman.
Malaysia, Indonesia and Singapore.
One coordinated strategy across several jurisdictions at once.
Protocol
Market-specific screening against each regulator's permitted list.
The route to market, with the evidence each regulator will ask for.
Compliance review of the label, and claims graded against the literature.
Documentation prepared and lodged through the relevant portal.
For Australian brands planning to export, international brands entering Australia, and founders launching across several markets at once.
Questions
The TGA in Australia, CPNP in the European Union, SCPN in the United Kingdom, SFDA across the GCC, and the Southeast Asian regulators in Malaysia, Indonesia and Singapore. Several markets can run as one coordinated strategy rather than one after another.
Yes. Claims are graded against the published literature and against each regulator's permitted indications, so you know which survive scrutiny and which need rewording, before the label goes to print rather than after.
It is flagged during the ingredient review and we propose alternatives that hold the formula's intent. Finding it at submission, with packaging already printed, is what costs months.
Both. The dossier is prepared and lodged through the relevant portal, and the documentation stays with you afterwards.
It depends on the market and on the regulator's own queue. We scope an indicative timeline per jurisdiction in the proposal rather than promise a date that is not ours to control.
Yes. An existing formula can be screened against a target market's permitted lists and its claims assessed against the evidence, before you commit to the launch.
Next step
A focused conversation to understand your product and scope what's possible. No pressure, no pitch.